| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Phenylketonurias | 45 | 2024 | 126 | 9.110 |
Why?
|
| Neonatal Screening | 26 | 2024 | 597 | 3.680 |
Why?
|
| Phenylalanine | 27 | 2021 | 364 | 2.780 |
Why?
|
| Galactosemias | 12 | 2021 | 124 | 2.350 |
Why?
|
| Metabolism, Inborn Errors | 10 | 2016 | 284 | 1.350 |
Why?
|
| Urea Cycle Disorders, Inborn | 3 | 2019 | 32 | 1.260 |
Why?
|
| Amino Acid Metabolism, Inborn Errors | 5 | 2022 | 283 | 1.130 |
Why?
|
| Parents | 13 | 2021 | 3564 | 1.050 |
Why?
|
| Phenylketonuria, Maternal | 9 | 2003 | 15 | 0.990 |
Why?
|
| Diet, Protein-Restricted | 2 | 2021 | 72 | 0.880 |
Why?
|
| UTP-Hexose-1-Phosphate Uridylyltransferase | 5 | 2021 | 68 | 0.840 |
Why?
|
| Acyl-CoA Dehydrogenase | 7 | 2017 | 57 | 0.820 |
Why?
|
| Methylmalonyl-CoA Mutase | 1 | 2022 | 23 | 0.810 |
Why?
|
| Mucopolysaccharidosis II | 1 | 2021 | 26 | 0.780 |
Why?
|
| Child Development | 9 | 2021 | 2302 | 0.680 |
Why?
|
| Food Preferences | 1 | 2023 | 398 | 0.680 |
Why?
|
| Pregnancy Complications | 19 | 2017 | 2949 | 0.670 |
Why?
|
| Intelligence | 17 | 2010 | 922 | 0.670 |
Why?
|
| Lipid Metabolism, Inborn Errors | 4 | 2017 | 123 | 0.650 |
Why?
|
| Cognition | 13 | 2024 | 6988 | 0.640 |
Why?
|
| Citrullinemia | 1 | 2018 | 3 | 0.620 |
Why?
|
| Argininosuccinic Aciduria | 1 | 2018 | 11 | 0.610 |
Why?
|
| Hyperargininemia | 1 | 2018 | 12 | 0.610 |
Why?
|
| Developmental Disabilities | 9 | 2020 | 1510 | 0.590 |
Why?
|
| Infant, Newborn | 46 | 2024 | 26199 | 0.570 |
Why?
|
| Diet Surveys | 1 | 2021 | 1161 | 0.570 |
Why?
|
| Angelman Syndrome | 6 | 2019 | 139 | 0.520 |
Why?
|
| Neuropsychological Tests | 15 | 2024 | 7046 | 0.510 |
Why?
|
| Metabolic Diseases | 4 | 2017 | 680 | 0.470 |
Why?
|
| Child | 55 | 2024 | 80152 | 0.460 |
Why?
|
| Genetic Testing | 3 | 2018 | 3537 | 0.410 |
Why?
|
| Child, Preschool | 34 | 2021 | 42224 | 0.410 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 4 | 2021 | 3707 | 0.400 |
Why?
|
| Intelligence Tests | 8 | 2019 | 503 | 0.390 |
Why?
|
| Mothers | 6 | 2021 | 2193 | 0.390 |
Why?
|
| Stress, Psychological | 5 | 2016 | 4487 | 0.380 |
Why?
|
| Family Health | 2 | 2006 | 1254 | 0.380 |
Why?
|
| Alleles | 1 | 2021 | 6857 | 0.350 |
Why?
|
| Mitochondrial Diseases | 2 | 2017 | 342 | 0.350 |
Why?
|
| Cognition Disorders | 8 | 2012 | 3976 | 0.330 |
Why?
|
| Clinical Trials as Topic | 2 | 2024 | 8003 | 0.320 |
Why?
|
| Hyperammonemia | 3 | 2019 | 76 | 0.310 |
Why?
|
| Infant | 27 | 2021 | 36169 | 0.310 |
Why?
|
| False Positive Reactions | 6 | 2009 | 958 | 0.300 |
Why?
|
| Postpartum Period | 1 | 2014 | 1178 | 0.290 |
Why?
|
| Health Knowledge, Attitudes, Practice | 3 | 2021 | 4014 | 0.290 |
Why?
|
| Glutamine | 3 | 2018 | 574 | 0.280 |
Why?
|
| Humans | 120 | 2024 | 761208 | 0.280 |
Why?
|
| Adolescent | 40 | 2021 | 88298 | 0.280 |
Why?
|
| Pregnancy Outcome | 12 | 2004 | 2923 | 0.270 |
Why?
|
| Social Support | 8 | 2004 | 2175 | 0.260 |
Why?
|
| Female | 86 | 2021 | 392544 | 0.260 |
Why?
|
| Genetic Variation | 1 | 2021 | 6567 | 0.260 |
Why?
|
| Rare Diseases | 3 | 2019 | 624 | 0.260 |
Why?
|
| Prenatal Care | 3 | 2004 | 1141 | 0.260 |
Why?
|
| Infant, Newborn, Diseases | 3 | 2009 | 589 | 0.260 |
Why?
|
| Homocystinuria | 3 | 2019 | 64 | 0.260 |
Why?
|
| Betaine | 2 | 2019 | 90 | 0.250 |
Why?
|
| Adult | 56 | 2021 | 221119 | 0.250 |
Why?
|
| Chromosomes, Human, Pair 15 | 4 | 2011 | 361 | 0.250 |
Why?
|
| Family Practice | 1 | 2008 | 507 | 0.250 |
Why?
|
| Methylmalonic Acid | 2 | 2022 | 49 | 0.240 |
Why?
|
| Fatty Acids | 1 | 2013 | 1807 | 0.240 |
Why?
|
| Patient Compliance | 7 | 2004 | 2688 | 0.230 |
Why?
|
| Social Behavior | 2 | 2011 | 1136 | 0.230 |
Why?
|
| Male | 55 | 2021 | 360693 | 0.220 |
Why?
|
| Prejudice | 1 | 2008 | 572 | 0.220 |
Why?
|
| Research Support as Topic | 1 | 2008 | 697 | 0.220 |
Why?
|
| Sick Role | 1 | 2004 | 229 | 0.220 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2016 | 3634 | 0.220 |
Why?
|
| Pregnancy | 31 | 2017 | 29893 | 0.210 |
Why?
|
| Research Personnel | 1 | 2008 | 588 | 0.210 |
Why?
|
| Histidine | 1 | 2004 | 303 | 0.210 |
Why?
|
| Homozygote | 3 | 2019 | 1775 | 0.210 |
Why?
|
| Glutarates | 1 | 2004 | 243 | 0.210 |
Why?
|
| Attitude to Health | 6 | 2018 | 2026 | 0.210 |
Why?
|
| Executive Function | 3 | 2020 | 1388 | 0.200 |
Why?
|
| Physicians, Women | 1 | 2008 | 510 | 0.190 |
Why?
|
| Fetal Diseases | 4 | 2004 | 912 | 0.190 |
Why?
|
| Phenylalanine Hydroxylase | 2 | 2018 | 28 | 0.190 |
Why?
|
| Longitudinal Studies | 13 | 2019 | 14610 | 0.190 |
Why?
|
| Translations | 1 | 2021 | 81 | 0.190 |
Why?
|
| Mental Disorders | 5 | 2019 | 6823 | 0.190 |
Why?
|
| Europe | 2 | 2019 | 3423 | 0.180 |
Why?
|
| Quality Improvement | 1 | 2016 | 3808 | 0.180 |
Why?
|
| Peer Group | 2 | 2004 | 691 | 0.180 |
Why?
|
| Phenotype | 10 | 2021 | 16575 | 0.180 |
Why?
|
| Child Behavior | 2 | 2003 | 848 | 0.180 |
Why?
|
| Faculty, Medical | 1 | 2008 | 1205 | 0.160 |
Why?
|
| Mitochondrial Encephalomyopathies | 1 | 1999 | 40 | 0.160 |
Why?
|
| Ornithine Carbamoyltransferase Deficiency Disease | 1 | 2019 | 23 | 0.160 |
Why?
|
| Fellowships and Scholarships | 1 | 2008 | 1115 | 0.160 |
Why?
|
| Mitochondrial Myopathies | 1 | 1999 | 50 | 0.160 |
Why?
|
| Vitamin B 12 | 1 | 2022 | 524 | 0.160 |
Why?
|
| Arginine | 2 | 2018 | 920 | 0.160 |
Why?
|
| Follow-Up Studies | 11 | 2021 | 39126 | 0.160 |
Why?
|
| Genotype | 7 | 2021 | 12985 | 0.160 |
Why?
|
| Folic Acid | 2 | 2019 | 1323 | 0.160 |
Why?
|
| Young Adult | 14 | 2020 | 59221 | 0.160 |
Why?
|
| Neuronal Ceroid-Lipofuscinoses | 1 | 2019 | 134 | 0.150 |
Why?
|
| Parenting | 1 | 2004 | 701 | 0.150 |
Why?
|
| Neurites | 1 | 2020 | 391 | 0.150 |
Why?
|
| Tyrosinemias | 1 | 2017 | 10 | 0.150 |
Why?
|
| Citrulline | 1 | 2018 | 107 | 0.150 |
Why?
|
| Emotions | 1 | 2010 | 2742 | 0.150 |
Why?
|
| Language Development Disorders | 2 | 2013 | 193 | 0.140 |
Why?
|
| Ammonia | 1 | 2018 | 243 | 0.140 |
Why?
|
| Diet Therapy | 2 | 2017 | 151 | 0.140 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2019 | 457 | 0.140 |
Why?
|
| Mutagenesis, Insertional | 1 | 2019 | 657 | 0.140 |
Why?
|
| Genetic Diseases, Inborn | 2 | 2020 | 603 | 0.140 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2021 | 17897 | 0.140 |
Why?
|
| Depression, Postpartum | 1 | 2021 | 349 | 0.140 |
Why?
|
| Age of Onset | 2 | 2019 | 3307 | 0.130 |
Why?
|
| Adaptation, Psychological | 3 | 2021 | 2632 | 0.130 |
Why?
|
| Carnitine | 2 | 2017 | 252 | 0.130 |
Why?
|
| Psychometrics | 4 | 2020 | 3061 | 0.130 |
Why?
|
| Statistics, Nonparametric | 5 | 2011 | 2854 | 0.130 |
Why?
|
| Mother-Child Relations | 1 | 1999 | 495 | 0.120 |
Why?
|
| Canada | 2 | 2017 | 2125 | 0.110 |
Why?
|
| Membrane Transport Proteins | 1 | 2019 | 1031 | 0.110 |
Why?
|
| Mental Processes | 1 | 1994 | 244 | 0.110 |
Why?
|
| Coma | 1 | 2017 | 484 | 0.110 |
Why?
|
| United States | 10 | 2023 | 72339 | 0.110 |
Why?
|
| Depression | 3 | 2021 | 8132 | 0.100 |
Why?
|
| Middle Aged | 13 | 2021 | 220853 | 0.100 |
Why?
|
| Home Care Services | 1 | 1999 | 647 | 0.100 |
Why?
|
| Motor Skills Disorders | 1 | 2013 | 89 | 0.100 |
Why?
|
| Pregnancy in Diabetics | 1 | 1993 | 197 | 0.100 |
Why?
|
| Hypothyroidism | 3 | 2003 | 668 | 0.100 |
Why?
|
| Psychological Tests | 3 | 2007 | 639 | 0.100 |
Why?
|
| Family Planning Services | 2 | 1993 | 267 | 0.100 |
Why?
|
| Congenital Abnormalities | 3 | 2000 | 707 | 0.100 |
Why?
|
| Mutation | 6 | 2022 | 30002 | 0.100 |
Why?
|
| Patient Education as Topic | 2 | 1999 | 2317 | 0.090 |
Why?
|
| Thyroxine | 3 | 2011 | 665 | 0.090 |
Why?
|
| Galactose | 3 | 2019 | 294 | 0.090 |
Why?
|
| Neurologic Examination | 2 | 2008 | 915 | 0.090 |
Why?
|
| Agoraphobia | 1 | 1991 | 177 | 0.090 |
Why?
|
| Sequence Deletion | 2 | 2019 | 1487 | 0.090 |
Why?
|
| Case-Control Studies | 9 | 2020 | 22174 | 0.090 |
Why?
|
| Analysis of Variance | 4 | 2004 | 6223 | 0.090 |
Why?
|
| Medical Records | 2 | 2013 | 1409 | 0.080 |
Why?
|
| Erythrocytes | 1 | 2019 | 2413 | 0.080 |
Why?
|
| Personality Disorders | 1 | 1994 | 719 | 0.080 |
Why?
|
| Contraception Behavior | 1 | 1991 | 180 | 0.080 |
Why?
|
| Anxiety | 2 | 2019 | 4569 | 0.080 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2011 | 732 | 0.080 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2020 | 2787 | 0.080 |
Why?
|
| Sequence Analysis, DNA | 2 | 2018 | 4739 | 0.080 |
Why?
|
| Retrospective Studies | 9 | 2021 | 80674 | 0.080 |
Why?
|
| Death, Sudden | 1 | 2010 | 301 | 0.080 |
Why?
|
| Tyrosine | 3 | 2010 | 1422 | 0.080 |
Why?
|
| Cross-Sectional Studies | 4 | 2023 | 26071 | 0.070 |
Why?
|
| Interviews as Topic | 3 | 2009 | 2697 | 0.070 |
Why?
|
| Wolff-Parkinson-White Syndrome | 1 | 2008 | 116 | 0.070 |
Why?
|
| Prenatal Exposure Delayed Effects | 4 | 2011 | 2517 | 0.070 |
Why?
|
| MMPI | 2 | 1999 | 81 | 0.070 |
Why?
|
| Ubiquitin-Protein Ligases | 3 | 2011 | 1892 | 0.070 |
Why?
|
| Mass Spectrometry | 3 | 2003 | 2189 | 0.070 |
Why?
|
| Time Factors | 5 | 2016 | 39957 | 0.070 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2017 | 3770 | 0.070 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2008 | 342 | 0.070 |
Why?
|
| Personality | 2 | 1993 | 553 | 0.070 |
Why?
|
| Oxidation-Reduction | 1 | 2013 | 2227 | 0.070 |
Why?
|
| Nervous System | 1 | 2010 | 545 | 0.070 |
Why?
|
| Quality of Life | 3 | 2022 | 13367 | 0.070 |
Why?
|
| Treatment Outcome | 7 | 2019 | 64681 | 0.070 |
Why?
|
| Databases, Bibliographic | 1 | 2006 | 130 | 0.070 |
Why?
|
| Fetal Blood | 3 | 1990 | 1348 | 0.070 |
Why?
|
| Birth Weight | 6 | 2004 | 2104 | 0.060 |
Why?
|
| Pregnancy Trimester, First | 1 | 2010 | 908 | 0.060 |
Why?
|
| Diet | 1 | 2023 | 8048 | 0.060 |
Why?
|
| Galactosephosphates | 1 | 2004 | 9 | 0.060 |
Why?
|
| Galactitol | 1 | 2004 | 6 | 0.060 |
Why?
|
| Brain Mapping | 1 | 2020 | 6635 | 0.060 |
Why?
|
| Muscular Dystrophy, Duchenne | 1 | 2007 | 265 | 0.060 |
Why?
|
| Communication | 3 | 2008 | 3872 | 0.060 |
Why?
|
| Massachusetts | 2 | 2016 | 8837 | 0.060 |
Why?
|
| Chromosome Aberrations | 1 | 2011 | 1767 | 0.060 |
Why?
|
| New England | 3 | 2001 | 1052 | 0.060 |
Why?
|
| Health Education | 1 | 1990 | 1049 | 0.060 |
Why?
|
| Genetic Counseling | 2 | 2018 | 628 | 0.060 |
Why?
|
| Comorbidity | 1 | 2018 | 10516 | 0.060 |
Why?
|
| Awards and Prizes | 1 | 2008 | 362 | 0.050 |
Why?
|
| Depressive Disorder, Major | 1 | 2021 | 4767 | 0.050 |
Why?
|
| Multivariate Analysis | 2 | 2016 | 12052 | 0.050 |
Why?
|
| Vitamin B Complex | 2 | 2019 | 299 | 0.050 |
Why?
|
| Educational Measurement | 1 | 1990 | 1250 | 0.050 |
Why?
|
| Biotinidase Deficiency | 1 | 2002 | 3 | 0.050 |
Why?
|
| Reproducibility of Results | 1 | 2021 | 20119 | 0.050 |
Why?
|
| Program Evaluation | 2 | 2004 | 2489 | 0.050 |
Why?
|
| Cystathionine beta-Synthase | 1 | 2002 | 27 | 0.050 |
Why?
|
| Maple Syrup Urine Disease | 1 | 2002 | 40 | 0.050 |
Why?
|
| Genome, Human | 1 | 2016 | 4423 | 0.050 |
Why?
|
| Logistic Models | 4 | 2003 | 13249 | 0.050 |
Why?
|
| Cooperative Behavior | 1 | 2010 | 1506 | 0.050 |
Why?
|
| Psychomotor Disorders | 1 | 2003 | 149 | 0.050 |
Why?
|
| Chromosome Deletion | 1 | 2007 | 1386 | 0.050 |
Why?
|
| Acyl-CoA Dehydrogenases | 1 | 2002 | 24 | 0.050 |
Why?
|
| Odds Ratio | 1 | 2014 | 9652 | 0.050 |
Why?
|
| Maternal-Fetal Exchange | 2 | 2003 | 461 | 0.050 |
Why?
|
| Neurodegenerative Diseases | 1 | 2011 | 1085 | 0.050 |
Why?
|
| Language Disorders | 1 | 1983 | 140 | 0.050 |
Why?
|
| Prospective Studies | 9 | 2014 | 54435 | 0.050 |
Why?
|
| Speech Disorders | 1 | 1983 | 180 | 0.050 |
Why?
|
| Disease Progression | 3 | 2016 | 13511 | 0.050 |
Why?
|
| Head | 3 | 2003 | 922 | 0.050 |
Why?
|
| National Institutes of Health (U.S.) | 2 | 2016 | 793 | 0.050 |
Why?
|
| Schools, Medical | 1 | 2008 | 878 | 0.050 |
Why?
|
| Factor Analysis, Statistical | 1 | 2004 | 998 | 0.050 |
Why?
|
| Plasma Membrane Neurotransmitter Transport Proteins | 1 | 2020 | 23 | 0.050 |
Why?
|
| Verbal Learning | 1 | 2003 | 463 | 0.050 |
Why?
|
| Iodine | 1 | 2003 | 285 | 0.050 |
Why?
|
| Boston | 2 | 2017 | 9327 | 0.050 |
Why?
|
| Brain Diseases, Metabolic, Inborn | 1 | 2020 | 46 | 0.040 |
Why?
|
| Brain | 3 | 2017 | 27092 | 0.040 |
Why?
|
| Mental Retardation, X-Linked | 1 | 2020 | 41 | 0.040 |
Why?
|
| Educational Status | 2 | 2007 | 2510 | 0.040 |
Why?
|
| DNA Methylation | 2 | 2011 | 4384 | 0.040 |
Why?
|
| Cystathionine gamma-Lyase | 1 | 1999 | 36 | 0.040 |
Why?
|
| Mitochondria | 1 | 2013 | 3620 | 0.040 |
Why?
|
| Aged | 4 | 2021 | 169288 | 0.040 |
Why?
|
| Child Behavior Disorders | 1 | 2003 | 804 | 0.040 |
Why?
|
| Genomic Imprinting | 2 | 2010 | 323 | 0.040 |
Why?
|
| Dietary Supplements | 1 | 2011 | 3410 | 0.040 |
Why?
|
| Health Care Costs | 3 | 2018 | 3239 | 0.040 |
Why?
|
| Creatine | 1 | 2020 | 427 | 0.040 |
Why?
|
| Enzyme Assays | 1 | 2019 | 104 | 0.040 |
Why?
|
| Autistic Disorder | 1 | 2007 | 1222 | 0.040 |
Why?
|
| Nitrobenzoates | 1 | 2017 | 16 | 0.040 |
Why?
|
| Reproduction | 1 | 2002 | 646 | 0.040 |
Why?
|
| Twins, Monozygotic | 1 | 2019 | 470 | 0.040 |
Why?
|
| Electroencephalography | 3 | 2020 | 6242 | 0.040 |
Why?
|
| Cyclohexanones | 1 | 2017 | 30 | 0.040 |
Why?
|
| Drugs, Investigational | 1 | 2019 | 212 | 0.040 |
Why?
|
| Sodium Benzoate | 1 | 2017 | 14 | 0.040 |
Why?
|
| Problem Solving | 1 | 2020 | 443 | 0.040 |
Why?
|
| Hydroxyproline | 1 | 1997 | 110 | 0.040 |
Why?
|
| Memory, Short-Term | 2 | 2020 | 982 | 0.040 |
Why?
|
| Phenylacetates | 1 | 2017 | 111 | 0.040 |
Why?
|
| Double-Blind Method | 3 | 2019 | 12341 | 0.030 |
Why?
|
| Attention | 2 | 2007 | 2394 | 0.030 |
Why?
|
| Acyl-CoA Dehydrogenase, Long-Chain | 1 | 2017 | 49 | 0.030 |
Why?
|
| Parent-Child Relations | 1 | 2021 | 762 | 0.030 |
Why?
|
| Anisotropy | 1 | 2020 | 1284 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 1 | 2014 | 7400 | 0.030 |
Why?
|
| Thyroid Gland | 1 | 2003 | 1169 | 0.030 |
Why?
|
| Fetus | 1 | 1983 | 1864 | 0.030 |
Why?
|
| Child Language | 2 | 2010 | 62 | 0.030 |
Why?
|
| Glutamates | 1 | 2017 | 385 | 0.030 |
Why?
|
| Socioeconomic Factors | 2 | 2003 | 7804 | 0.030 |
Why?
|
| Wechsler Scales | 2 | 2007 | 257 | 0.030 |
Why?
|
| Remote Sensing Technology | 1 | 2016 | 92 | 0.030 |
Why?
|
| Disease Management | 2 | 2017 | 2507 | 0.030 |
Why?
|
| Diseases in Twins | 1 | 1997 | 446 | 0.030 |
Why?
|
| Gestational Age | 1 | 2004 | 3580 | 0.030 |
Why?
|
| Gastrointestinal Agents | 1 | 2019 | 509 | 0.030 |
Why?
|
| Propionates | 1 | 1995 | 181 | 0.030 |
Why?
|
| Infant, Premature, Diseases | 1 | 2020 | 710 | 0.030 |
Why?
|
| Sex Factors | 1 | 2008 | 10553 | 0.030 |
Why?
|
| Memory | 1 | 2003 | 2190 | 0.030 |
Why?
|
| Thyrotropin | 3 | 2003 | 833 | 0.030 |
Why?
|
| Evidence-Based Medicine | 2 | 2016 | 3691 | 0.030 |
Why?
|
| Self-Help Groups | 1 | 1994 | 192 | 0.030 |
Why?
|
| Age Factors | 4 | 2011 | 18384 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 2008 | 12976 | 0.030 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2019 | 1186 | 0.030 |
Why?
|
| Muscular Diseases | 1 | 2017 | 552 | 0.030 |
Why?
|
| Health Behavior | 1 | 2004 | 2641 | 0.030 |
Why?
|
| Internal-External Control | 1 | 1993 | 358 | 0.020 |
Why?
|
| Food | 1 | 1997 | 768 | 0.020 |
Why?
|
| Informed Consent | 1 | 2018 | 1008 | 0.020 |
Why?
|
| Drug Discovery | 1 | 2019 | 1050 | 0.020 |
Why?
|
| Delivery of Health Care | 1 | 2009 | 5333 | 0.020 |
Why?
|
| Data Collection | 3 | 2011 | 3320 | 0.020 |
Why?
|
| Language | 1 | 2020 | 1539 | 0.020 |
Why?
|
| Lipotropic Agents | 1 | 2010 | 13 | 0.020 |
Why?
|
| Family | 2 | 2018 | 3192 | 0.020 |
Why?
|
| Ovarian Diseases | 1 | 2012 | 137 | 0.020 |
Why?
|
| Osmolar Concentration | 1 | 2011 | 659 | 0.020 |
Why?
|
| Uniparental Disomy | 1 | 2010 | 45 | 0.020 |
Why?
|
| Reference Values | 2 | 2011 | 4921 | 0.020 |
Why?
|
| Health Status | 1 | 2003 | 4077 | 0.020 |
Why?
|
| Infant, Premature | 1 | 2020 | 2106 | 0.020 |
Why?
|
| Motor Activity | 1 | 2020 | 2712 | 0.020 |
Why?
|
| Disabled Persons | 1 | 1980 | 1224 | 0.020 |
Why?
|
| Sensitivity and Specificity | 2 | 2019 | 14675 | 0.020 |
Why?
|
| Pediatrics | 1 | 2005 | 3590 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2008 | 3777 | 0.020 |
Why?
|
| Registries | 2 | 2019 | 8247 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2004 | 9319 | 0.020 |
Why?
|
| Cohort Studies | 3 | 2019 | 41496 | 0.020 |
Why?
|
| Interpersonal Relations | 2 | 2011 | 1437 | 0.020 |
Why?
|
| Interinstitutional Relations | 1 | 2010 | 236 | 0.020 |
Why?
|
| Alagille Syndrome | 1 | 2008 | 45 | 0.020 |
Why?
|
| Gastric Bypass | 1 | 2017 | 818 | 0.020 |
Why?
|
| Maternal-Child Health Centers | 1 | 1988 | 42 | 0.020 |
Why?
|
| Thyroid Diseases | 1 | 2011 | 386 | 0.020 |
Why?
|
| Evaluation Studies as Topic | 1 | 1990 | 1624 | 0.020 |
Why?
|
| Child of Impaired Parents | 1 | 2011 | 460 | 0.020 |
Why?
|
| Facies | 1 | 2008 | 222 | 0.020 |
Why?
|
| Self Concept | 1 | 1993 | 1046 | 0.020 |
Why?
|
| United States Food and Drug Administration | 1 | 2016 | 1662 | 0.020 |
Why?
|
| Biopsy | 1 | 2019 | 6781 | 0.020 |
Why?
|
| Motor Skills | 1 | 2010 | 521 | 0.020 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2008 | 473 | 0.020 |
Why?
|
| Dietary Carbohydrates | 1 | 2012 | 891 | 0.020 |
Why?
|
| Chromosome Breakage | 1 | 2007 | 159 | 0.020 |
Why?
|
| Seizures | 1 | 2019 | 2965 | 0.020 |
Why?
|
| Internationality | 1 | 2012 | 999 | 0.020 |
Why?
|
| Patient Selection | 1 | 2018 | 4246 | 0.020 |
Why?
|
| Placebos | 1 | 2010 | 1666 | 0.020 |
Why?
|
| Attitude | 1 | 1991 | 771 | 0.020 |
Why?
|
| Skin | 1 | 2019 | 4473 | 0.020 |
Why?
|
| Creatine Kinase | 1 | 2007 | 684 | 0.020 |
Why?
|
| Medication Adherence | 1 | 2017 | 2175 | 0.020 |
Why?
|
| Liver Transplantation | 1 | 2017 | 2332 | 0.020 |
Why?
|
| Genomics | 1 | 2021 | 5828 | 0.020 |
Why?
|
| Health | 1 | 1988 | 398 | 0.020 |
Why?
|
| Personality Tests | 1 | 1984 | 80 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2019 | 12747 | 0.010 |
Why?
|
| Cardiomyopathies | 1 | 2017 | 2021 | 0.010 |
Why?
|
| Drug Combinations | 1 | 2010 | 2048 | 0.010 |
Why?
|
| Prognosis | 2 | 2004 | 29687 | 0.010 |
Why?
|
| Gene Dosage | 1 | 2008 | 1217 | 0.010 |
Why?
|
| Caregivers | 1 | 2016 | 2244 | 0.010 |
Why?
|
| Calcium-Binding Proteins | 1 | 2008 | 1067 | 0.010 |
Why?
|
| Hospitalization | 1 | 2003 | 10707 | 0.010 |
Why?
|
| Immunoglobulins, Thyroid-Stimulating | 1 | 2003 | 34 | 0.010 |
Why?
|
| Microcephaly | 2 | 1987 | 425 | 0.010 |
Why?
|
| Epidemiologic Methods | 1 | 1988 | 1336 | 0.010 |
Why?
|
| Speech Articulation Tests | 1 | 1983 | 4 | 0.010 |
Why?
|
| Pregnant Women | 1 | 1988 | 568 | 0.010 |
Why?
|
| Electronic Mail | 1 | 2005 | 213 | 0.010 |
Why?
|
| Thyroglobulin | 1 | 2003 | 111 | 0.010 |
Why?
|
| Embryonic and Fetal Development | 1 | 2003 | 420 | 0.010 |
Why?
|
| Homocystine | 1 | 2002 | 21 | 0.010 |
Why?
|
| Risk Factors | 5 | 2004 | 74239 | 0.010 |
Why?
|
| Amino Acids, Sulfur | 1 | 2002 | 16 | 0.010 |
Why?
|
| Gene Deletion | 1 | 2010 | 2658 | 0.010 |
Why?
|
| Language Tests | 1 | 1983 | 190 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2014 | 10756 | 0.010 |
Why?
|
| Pyridoxine | 1 | 2002 | 108 | 0.010 |
Why?
|
| Decision Making | 1 | 1995 | 3931 | 0.010 |
Why?
|
| Food, Formulated | 1 | 2002 | 101 | 0.010 |
Why?
|
| Probability | 1 | 1987 | 2478 | 0.010 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2008 | 1651 | 0.010 |
Why?
|
| Education, Distance | 1 | 2005 | 260 | 0.010 |
Why?
|
| Genetic Association Studies | 1 | 2010 | 2731 | 0.010 |
Why?
|
| Aging | 1 | 2020 | 8702 | 0.010 |
Why?
|
| Nutritional Status | 2 | 2002 | 1597 | 0.010 |
Why?
|
| State Health Plans | 1 | 2002 | 219 | 0.010 |
Why?
|
| Cystathionine | 1 | 1999 | 6 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2019 | 18220 | 0.010 |
Why?
|
| Education, Medical, Continuing | 1 | 2005 | 825 | 0.010 |
Why?
|
| Education | 1 | 2002 | 536 | 0.010 |
Why?
|
| Abortion, Spontaneous | 1 | 1983 | 533 | 0.010 |
Why?
|
| Denmark | 1 | 1980 | 770 | 0.010 |
Why?
|
| Body Height | 1 | 2003 | 1566 | 0.010 |
Why?
|
| Diabetes Mellitus | 1 | 1995 | 5842 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2018 | 24021 | 0.010 |
Why?
|
| Twins, Dizygotic | 1 | 1997 | 236 | 0.010 |
Why?
|
| Cross-Cultural Comparison | 1 | 1980 | 634 | 0.010 |
Why?
|
| Drug Resistance | 1 | 2002 | 1594 | 0.010 |
Why?
|
| Models, Statistical | 1 | 2011 | 5081 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 1991 | 3417 | 0.010 |
Why?
|
| Amino Acids | 1 | 2002 | 1703 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2008 | 9520 | 0.010 |
Why?
|
| Methylmalonyl-CoA Decarboxylase | 1 | 1995 | 3 | 0.010 |
Why?
|
| Muscle Tonus | 1 | 1995 | 82 | 0.010 |
Why?
|
| Carboxy-Lyases | 1 | 1995 | 85 | 0.010 |
Why?
|
| Electrocardiography | 1 | 2008 | 6387 | 0.010 |
Why?
|
| Delivery, Obstetric | 1 | 2002 | 941 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 2002 | 4107 | 0.010 |
Why?
|
| Body Weight | 1 | 1983 | 4618 | 0.010 |
Why?
|
| Gastrostomy | 1 | 1995 | 323 | 0.010 |
Why?
|
| Animals | 2 | 2019 | 168079 | 0.010 |
Why?
|
| Research | 1 | 2000 | 1976 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2008 | 7851 | 0.010 |
Why?
|
| Brain Injuries | 1 | 2003 | 2054 | 0.010 |
Why?
|
| Psychomotor Performance | 1 | 1999 | 1880 | 0.010 |
Why?
|
| Attitude of Health Personnel | 1 | 2005 | 3885 | 0.010 |
Why?
|
| Risk | 1 | 1983 | 9616 | 0.010 |
Why?
|
| Insurance Coverage | 1 | 2002 | 1935 | 0.010 |
Why?
|
| Enteral Nutrition | 1 | 1995 | 794 | 0.010 |
Why?
|
| Visual Perception | 1 | 1997 | 1385 | 0.000 |
Why?
|
| Health Services Accessibility | 1 | 2002 | 5425 | 0.000 |
Why?
|
| Mice | 1 | 2008 | 81326 | 0.000 |
Why?
|
| Prenatal Diagnosis | 1 | 1987 | 1267 | 0.000 |
Why?
|